Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06922097Completed
Randomised trial of atropine in bradycardia (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Average norepinephrine infusion rate. Started Apr 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06922097.